Most Popular on Medindia

P
M

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

by Raja Nandhini on  March 29, 2013 at 6:56 AM Drug News   - G J E 4
FDA has given its green signal for the new drug, Techfidera from Biogen, to treat multiple sclerosis. Multiple sclerosis is an autoimmune disorder causing difficulty in walking, vision and thinking, and has affected more than two million people worldwide.
 Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

Dimethyl fumarate is the chemical name of the drug and it is the compound previously used in Europe to protect shoes and sofas from moulds. But following reports of skin allergy the chemical was banned in Europe.

The drug had produced remarkable results in clinical trials and had cut down the relapse rate by nearly 49%. Moreover, the side effects if the drug seemed to be minimal when compared to other treatment options currently available. Side effects include flushing, diarrhea and nausea.

FDA has recommended testing white blood cell count once in every year after commencing the treatment.

This promising drug, which is available in a convenient pill form, is expected to hit the market very soon. The approval has hiked the share value of Biogen Idec Inc by 3.2%.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

Ask an Expert

C
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Ask an Expert

Ask an Expert+
s
New Synthetic Vaccines Developed to Treat Foot an...
 New Synthetic Vaccines Developed to Treat Foot and Mouth Disease
S  Vitamin D Deficiency During Pregnancy Associated With Various Health Complications
Vitamin D Deficiency During Pregnancy Associated ...